COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,652 Articles (22,913 medRxiv, 8,739 bioRxiv)

Most recent first Previous |  Page 1094: Articles 10931-10940  | Next

A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors
Chen, K.-Y., Krischuns, T., Ortega Varga, L., Harigua-Souiai, E., Paisant, S., Zettor, A., Chiaravalli, J., Courtney, D., O'Brien, A., Baker, S., Isel, C., Agou, F., Jacob, Y., Blondel, A., Naffakh, N.
10.1101/2021.12.18.473303 — Posted: 2021-12-21
APOBEC-mediated Editing of SARS-CoV-2 Genomic RNA Impacts Viral Replication and Fitness
Chen, X., Kim, K., Calabrese, P., Wang, S., Qin, C., Rao, Y., Feng, P.
10.1101/2021.12.18.473309 — Posted: 2021-12-21
ACE2-containing defensosomes serve as decoys to inhibit SARS-CoV-2 infection
Ching, K. L., de Vries, M., Gago, J., Dancel-Manning, K., Sall, J., Rice, W. J., Barnett, C., Liang, F.-X., Thorpe, L. E., Shopsin, B., Segal, L. N., Dittmann, M., Torres, V. J., Cadwell, K.
10.1101/2021.12.17.473223 — Posted: 2021-12-20
Evidence for a Potential Pre-Pandemic SARS-like Coronavirus Among Animals in North America
Hancock, T. J., Hickman, P., Kazerooni, N., Kennedy, M., Kania, S. A., Dennis, M., Szafranski, N., Gerhold, R. W., Su, C., Masi, T. J., Smith, S., Sparer, T. E.
10.1101/2021.12.17.473265 — Posted: 2021-12-20
A Computational Dissection of Spike protein of SARS-CoV-2 Omicron Variant
Rehman, Z., Umair, M., Ikram, A., Salman, M., Haider, S. A., Ammar, M.
10.1101/2021.12.17.473260 — Posted: 2021-12-20 Discussion: Onsite
The rise and fall of SARS-CoV-2 variants and the mutational profile of Omicron
Wiegand, T. R., McVey, A., Nemudraia, A., Nemudryi, A., Wiedenheft, B.
10.1101/2021.12.16.473096 — Posted: 2021-12-20
Unraveling the antiviral activity of plitidepsin by subcellular and morphological analysis
Sachse, M., Tenorio, R., Fernandez de Castro, I., Munoz-Basagoiti, J., Perez-Zsolt, D., Raich-Regue, D., Rodo, J., Losada, A., Aviles, P., Cuevas, C., Paredes, R., Segales, J., Clotet, B., Vergara-Alert, J., Izquierdo-Useros, N., Risco, C.
10.1101/2021.12.16.472880 — Posted: 2021-12-20
Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice
Puhl, A. C., Gomes, G. F., Damasceno, S., Fritch, E. J., Levi, J. A., Johnson, N. J., Scholle, F., Premkumar, L., Hurst, B. L., LeeMontiel, F., Veras, F. P., Batah, S. S., Fabro, A. T., Moorman, N. J., Yount, B., Dickmander, R., Baric, R. S., Pearce, K. H., Cunha, F., Alves-Filho, J. C., Cunha, T., Ekins, S.
10.1101/2021.12.16.472155 — Posted: 2021-12-20
Modeling and predicting the overlap of B- and T-cell receptor repertoires in healthy and SARS-CoV-2 infected individuals
Ruiz Ortega, M., Spisak, N., Mora, T., Walczak, A. M.
10.1101/2021.12.17.473105 — Posted: 2021-12-20
Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)
Sheward, D. J., Kim, C., Ehling, R. A., Pankow, A., Castro Dopico, X., Martin, D. P., Reddy, S. T., Dillner, J., Karlsson Hedestam, G. B., Albert, J., Murrell, B.
10.1101/2021.12.19.473354 — Posted: 2021-12-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).